Vizora日本語

StemCell InstituteStemCell Institute Inc.7096東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

StemCell Institute FY ending Mar 2024 results

StemCell Institute brought in ¥2.48B in revenue.

Out of every ¥100 of sales, about ¥17 is left as operating profit.

Revenue changed +18.6% from the prior year, operating profit +39.1%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +18.6% · profit +39.1%, calculated from disclosed figures.

Operating leverage: 2.09× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2023 → FY ending Mar 2024

Revenue
+18.6%¥2.09B → ¥2.48B
Gross profit
+18.0%¥1.34B → ¥1.58B
Operating income
+39.1%¥297.6M → ¥413.8M
Operating cash flow
+235.7%¥99.7M → ¥334.6M
Free cash flow
+234.4%¥39.8M → ¥133M

Where the money goes

FY ending Mar 2023 → FY ending Mar 2024

Where ¥100 of sales goes

For every ¥100 StemCell Institute sells, how much goes where, and how much is kept.

FY ending Mar 2024
Cost of sales
¥36
SG&A
¥47
Operating profit
¥17
Net profit kept
¥13

Annual margin trends

Gross margin63.5%
FY ending Mar 2020: 67.6%67.6%FY ending Mar 2021: 65.6%65.6%FY ending Mar 2022: 62.4%62.4%FY ending Mar 2023: 63.9%63.9%FY ending Mar 2024: 63.5%63.5%FY20FY21FY22FY23FY24
Operating margin16.7%
FY ending Mar 2020: 22.8%22.8%FY ending Mar 2021: 6.2%6.2%FY ending Mar 2022: 12.7%12.7%FY ending Mar 2023: 14.2%14.2%FY ending Mar 2024: 16.7%16.7%FY20FY21FY22FY23FY24
Net margin12.5%
FY ending Mar 2020: 16.6%16.6%FY ending Mar 2021: 4.4%4.4%FY ending Mar 2022: 7.5%7.5%FY ending Mar 2023: 9.5%9.5%FY ending Mar 2024: 12.5%12.5%FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Sources

Show source documents (5)

  • EDINET (FSA Japan)

    有価証券報告書－第26期(2024/04/01－2025/03/31)

    ID S100W2VG2025-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第25期(2023/04/01－2024/03/31)

    ID S100TW622024-06-27Open

  • EDINET (FSA Japan)

    有価証券報告書－第24期(2022/04/01－2023/03/31)

    ID S100R2C52023-06-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第23期(令和3年4月1日－令和4年3月31日)

    ID S100OD0Y2022-06-24Open

  • EDINET (FSA Japan)

    有価証券報告書－第22期(令和2年4月1日－令和3年3月31日)

    ID S100LVGX2021-06-30Open

Extracted from XBRL: 42 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image